Dr. Ruth Roberts is chair of drug discovery at Birmingham University, UK (2016 to date) and Codirector and Cofounder of ApconiX, an integrated toxicology and ion channel research company (2014 to date). Before that, she was Head of Cancer Biology at ICI Central Toxicology Laboratory (1990–2002), Director of Toxicology for Aventis in Paris, France (2002–2004) and Global Head of Regulatory Safety at AstraZeneca (2004–2014). Ruth has previously served on the Board of ATS and is also a previous Chair of the ‘Mechanisms of Toxicity’ Gordon Conference, past Chair of the HESI emerging issues subcommittee and has been very active in the Society of Toxicology (SOT), serving in various roles such as Past-President of the Carcinogenicity specialty section and current Secretary to Council. As Past-President of the British Toxicology Society and Past-President of EUROTOX, she is also well known as a scientific leader in Europe. Throughout her career, Ruth has worked at the interface between industry and academia to drive collaboration and to bring rigorous expert thinking to toxicology, drug discovery and drug development. She is passionate about training the next generation of toxicologists and is a regular feature on Masters courses and training webinars in the US and in Europe. With >140 publications in peer reviewed journals, she was the recipient of the SOT Achievement award in 2002 and the EUROTOX Bo Holmstedt Award in 2009. Ruth received her doctoral degree in cell and molecular biology from the University of Manchester, UK before completing a postdoctoral fellowship in cancer biology at the University of London. In addition to being a Fellow of the ATS, she is a European Registered Toxicologist (ERT), a fellow of the Royal Society of Biology (FRSB) and a Fellow of the Royal College of Pathologists (FRCPath).